Beam Therapeutics’ $120 Million Acquisition of GuideTx

Orrick Herrington & Sutcliffe LLP advised Guide Therapeutics on the deal.Guide Therapeutics (GuideTx), a developer of nonviral drug delivery vehicles for genetic medicines, announced its acquisition by…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now